Patent Assignment
Reel/Frame 052920/0631
Release of Security Interest
Recorded: 2020-06-12
Pages: 9
Assignor
BLACK HORSE CAPITAL MASTER FUND LTD.
Executed: 2020-06-09
Assignee
HUMANIGEN, INC.
533 AIRPORT BLVD., SUITE 400, BURLINGAME, CALIFORNIA, 94010
Covered Properties
(22)
EPHA3 Antibodies for the Treatment of Pulmonary Fibrosis
PCT:
PCT/US2017/051406 ↗
Circularly Permutated, Interaction-Activated Proteins
Detection of Molecular Interactions by Beta-Lactamase Reporter Fragment Complementation
Antibody Specificity Transfer Using Minimal Essential Binding Determinants
Secretion of Antibodies Without Signal Peptides from Bacteria
EphA3 Antibodies for the Treatment of Solid Tumors
Antibodies to the Pcrv Antigen of Pseudomonas Aeruginosa
Methods of Treating Heart Failure Using an Anti-Gm-Csf Antibody
Antibodies to Granulocyte-Macrophage Colony-Stimulating Factor
Treatment of Leukemias and Chronic Myeloproliferative Diseases with Antibodies to EphA3
Antibodies to EPHA3
Antibodies to Granulocyte-Macrophage Colony-Stimulating Factor
Anti-EMR1 Antibodies
Secretion of antibodies without signal peptides from bacteria
Methods of Treating Hematological Proliferative Disorders by Targeting EPHA3 Expressed on Aberrant Vasculature in Bone Marrow
Antibodies to EPHA3
Immunoglobulin Variable Region Cassette Exchange
Methods of Treating Immunotherapy-Related Toxicity Using a Gm-Csf Antagonist
Method of reducing the level of non-GM-CSF cytokines/chemokines in immunotherapy-related toxicity
Method of Reducing Tumor Relapse Rate in Immunotherapy by Administration of Lenzilumab
Methods of Treating Cart-T Cell Therapy-Induced Neuroinflammation Using a Gm-Csf Antagonist
EPHA3 Antibodies for the Treatment of Pulmonary Fibrosis
Application:
16/333,094 →
Publication:
US 2019/0270821
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 26, 2012
From: YARRANTON, GEOFFREY T.; PALATH, VARGHESE; BEBBINGTON, CHRISTOPHER R.; BAER, MARK
To: KALOBIOS PHARMACEUTICALS, INC.
Reel/Frame 029196/0484 →
Assignment of Assignor's Interest
Nov 8, 2012
From: LUEHRSEN, KENNETH; BAER, MARK; BEBBINGTON, CHRISTOPHER R.; MARTINEZ, DAVID
To: KALOBIOS PHARMACEUTICALS, INC.
Reel/Frame 029267/0156 →
Assignment of Assignor's Interest
Jun 26, 2015
From: BEBBINGTON, CHRISTOPHER R.; LUEHRSEN, KENNETH; YARRANTON, GEOFFREY T.
To: KALOBIOS PHARMACEUTICALS, INC.
Reel/Frame 035918/0208 →
Assignment of Assignor's Interest
Feb 29, 2016
From: LUEHRSEN, KENNETH; MARTINEZ, DAVID; YI, CHRISTINA; BEBBINGTON, CHRISTOPHER R.
To: KALOBIOS PHARMACEUTICALS, INC.
Reel/Frame 037854/0777 →
Security Interest
May 23, 2016
From: KALOBIOS PHARMACEUTICALS, INC.
To: BLACK HORSE CAPITAL, LP
Reel/Frame 038788/0266 →
Security Interest
Dec 22, 2016
From: KALOBIOS PHARAMECUTICALS, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 041181/0605 →
Change of Name
Nov 6, 2017
From: KALOBIOS PHARMACEUTICALS, INC.
To: HUMANIGEN, INC.
Reel/Frame 044377/0915 →
Change of Name
Nov 6, 2017
From: KALOBIOS PHARMACEUTICALS, INC.
To: HUMANIGEN, INC.
Reel/Frame 044767/0814 →
Release of Security Interest
Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045788/0148 →
Release of Security Interest
Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045855/0533 →
Assignment of Assignor's Interest
Oct 5, 2018
From: DURRANT, CAMERON; CHAPPELL, DALE
To: HUMANIGEN, INC.
Reel/Frame 047083/0426 →
Assignment of Assignor's Interest
Mar 15, 2019
From: BEBBINGTON, CHRISTOPHER ROBERT; LUEHRSEN, KENNETH R.; YARRANTON, GEOFFREY T.
To: HUMANIGEN, INC.
Reel/Frame 048614/0012 →
Security Interest
Jul 16, 2019
From: HUMANIGEN, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 049769/0067 →
Change of Name
May 15, 2020
From: KALOBIOS PHARMACEUTICALS, INC.
To: HUMANIGEN, INC.
Reel/Frame 052679/0552 →
Change of Name
Jun 5, 2020
From: KALOBIOS PHARMACEUTICALS, INC.
To: HUMANIGEN, INC.
Reel/Frame 052858/0975 →
Change of Name
Dec 29, 2020
From: KALOBIOS PHARMACEUTICALS, INC.
To: HUMANIGEN, INC.
Reel/Frame 054869/0599 →